Tuesday, 02 January 2024 12:17 GMT

Bio-Rad, Poly Medicure, And Sekisui Medical Power Rapid Expansion In The Venous Blood Collection Market Through 2032


(MENAFN- GlobeNewsWire - Nasdaq) The venous blood collection market is poised for growth, driven by innovations in sampling technology and increasing demand due to chronic disease prevalence. Opportunities lie in automation, user safety, microfluidics, and regional supply chain resilience amidst evolving tariffs. Strategic partnerships and sustainability are key differentiators.

Dublin, Dec. 12, 2025 (GLOBE NEWSWIRE) -- The "Venous Blood Collection Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets's offering.
The venous blood collection market is experiencing significant growth, projected to increase from USD 4.68 billion in 2024 to USD 6.95 billion by 2032, with a compound annual growth rate (CAGR) of 5.07%. This upward trend reflects the crucial role these devices play in the global healthcare landscape, supporting diagnostic testing, therapeutic monitoring, and biomedical research. As demand for point-of-care diagnostics and patient safety rises, understanding technological innovations and regulatory shifts is essential for navigating this evolving market.

Market Dynamics: Innovation and Patient-Centric Design

Healthcare providers and manufacturers are driving advancements in venous blood collection to enhance patient safety, efficiency, and sample quality. Technologies such as microfluidic systems and automation are being integrated into current workflows, reducing hemolysis risk and optimizing turnaround times. These developments offer healthcare professionals improved ergonomic solutions and facilitate integration with laboratory information systems, creating strategic advantages in user settings.

Emerging Regulatory and Technological Landscapes

Regulatory bodies have enacted stringent standards focusing on sterilization, traceability, and quality, compelling manufacturers to enhance production processes. Technological strides towards automation and digital integration significantly impact clinical workflows by increasing throughput and minimizing human error. The focus on safety, connectivity, and sustainability is transforming competitive dynamics, enabling healthcare providers to offer reliable and efficient blood collection solutions, which is crucial for strategic planning.

  • The market is projected to grow at a 5.07% CAGR, reaching USD 6.95 billion by 2032.
  • Automation and microfluidic advancements streamline workflows and improve patient safety, supporting strategic decision-making.
  • The 2025 tariff measures demand a reassessment of supply chains, impacting cost structures.
  • Regional dynamics in markets like Asia-Pacific and Europe necessitate tailored approaches for competitive advantage.
  • Partnerships and collaborations drive innovation, while sustainability aligns with market trends and healthcare provider expectations.

Market Segmentation Insights

  • Product Type: Includes Blood Bags, Blood Collection Tubes (EDTA, Heparin), Lancets, Microfluidic Systems, and Needles.
  • Technology: Encompasses Automated Collection Systems and Vacuum Collection Technologies, crucial for efficiency.
  • Materials: Utilizes Ceramic, Glass, Stainless Steel, and Plastics like PET and PP for diverse applications.
  • Applications: Ranges from Intraoperative Blood Salvage to routine Venipuncture, accommodating clinical demands.
  • End Users: Target Blood Donation Centers, Diagnostic Centers, and Hospitals, each with unique needs.

Regional Dynamics

The report highlights strategic opportunities in diverse regions. The Americas lead with advanced infrastructure and regulatory pathways, while Europe faces a more heterogeneous landscape with rigorous standards. Asia-Pacific's expanding healthcare infrastructure drives demand for cost-effective, scalable solutions, with local manufacturing facilitating competitive strategies. Understanding these dynamics aids in identifying regional opportunities and planning effective market entries.


Key Attributes:

Report Attribute Details
No. of Pages 199
Forecast Period 2025 - 2032
Estimated Market Value (USD) in 2025 $4.9 Billion
Forecasted Market Value (USD) by 2032 $6.95 Billion
Compound Annual Growth Rate 5.0%
Regions Covered Global


Companies Featured
The companies profiled in this Venous Blood Collection market report include:

  • Abbott Laboratories
  • AdvaCare International
  • Baxter International Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biosigma S.p.A.
  • Cardinal Health, Inc.
  • Demophorius Limited
  • ELITech Group by Bruker Corporation
  • FL MEDICAL s.r.l.
  • Fresenius Kabi AG
  • Greiner Bio-One International GmbH
  • Medtronic PLC
  • Narang Medical Ltd.
  • Nipro Europe Group Companies
  • Plymouth Tube Company LLC
  • Poly Medicure Limited
  • PTS Diagnostics by Sinocare
  • QIAGEN GmbH
  • SARSTEDT AG & Co. KG
  • Sekisui Medical Co., Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
  • Zhejiang Gongdong Medical Technology Co., Ltd.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

  • Venous Blood Collection Market
CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN12122025004107003653ID1110472930



GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search